entertainment -WSS

entertainment

author：hotspot 2025-09-29 22:53:07 - browse：18

STAT@ASCO 2024 — Chris Boshoff, far right, speaking at a panel with, from left, Matthew Herper of STAT, Ken Keller, Levi Garraway, and Susan Galbraith. Megan Bearder Photography

CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today are making old ideas possible, said a panel of oncology industry leaders at STAT@ASCO, STAT’s event here at the annual American Society of Clinical Oncology meeting.

“We’re seeing this expansion in modalities. We have more types of modalities that have arrived or arriving that allow us to exploit targets we’ve known about more than ever before. It’s very exciting,” said Levi Garraway, the chief medical officer of Genentech, at the event. “Things we’ve known about for a long time can be drugged for the first time or in a new, different way.”

That’s led to a surge of new medicines ranging from small molecules to cell therapies, with the potential uses of these treatments expanding into earlier lines of therapy and more cancer types each year. One example the panel singled out is the drug Enhertu, which recently received a tumor-agnostic approval from the Food and Drug Administration.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： The response to Covid

WSS

What Henrietta Lacks's story taught me about my role as a doctor

RSV injection headlines need to be accurate for good uptake

The biotech scorecard for Q4: 16 stock

What will Novo Nordisk's VC do with its influx of cash?

Where does female orgasm come from? Scientists think they know

Some top drug companies are starting to take action on climate

explore

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Wikipedia

Virginia high school admissions case could be legal follow

Will an HIV vaccine ever be a reality?

The high cost of giving birth even with insurance

New requirements coming in 2024 for Americans traveling to Europe

Wildfire smoke exposes gaps in outdoor worker protections

New requirements coming in 2024 for Americans traveling to Europe

Alkermes shareholders re

Setback for rare diseases as Taysha Gene Therapies pulls back

Medicare proposal to cover medical devices draws a mixed reaction

FAMU bans football players from facility after release of rap video shot in team's locker room

entertainment

Study points to new risk in gene therapy death of Terry Horgan

CRISPR base editing slashes cholesterol levels in monkeys

Severe heat forecast: Where scorching temperatures will persist over the next week

2023 Nobel Prize in Medicine goes to Karikó and Weissman

FAMU bans football players from facility after release of rap video shot in team's locker room

Thousands protest mob assault of women who were paraded naked in remote Indian border state

knowledge

leisure time

focus

leisure time